Aurora Cannabis (ACB) Change in Accured Expenses (2017 - 2018)

Aurora Cannabis (ACB) posted quarterly Change in Accured Expenses of $3.6 million for Q4 2018, down 20.46% year-on-year from $4.5 million in Q4 2017, and down 79.47% on a QoQ basis from $17.4 million in Q3 2018.

Aurora Cannabis (ACB) Change in Accured Expenses (2017 - 2018) Analysis & Trends

Aurora Cannabis (ACB) has reported Change in Accured Expenses for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -12.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 3.56 Mn
Dec 31, 2018 3.56 Mn
Sep 30, 2018 17.35 Mn
Sep 30, 2018 17.35 Mn
Dec 31, 2017 4.48 Mn
Dec 31, 2017 4.48 Mn
Sep 30, 2017 -686,566.87
Sep 30, 2017 -686,566.87